Clinical Trials Logo

Intraocular Pressure clinical trials

View clinical trials related to Intraocular Pressure.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT00533962 Active, not recruiting - Glaucoma Clinical Trials

IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients

Start date: August 2007
Phase: N/A
Study type: Interventional

Introduction: Ocular administration of glucocorticoids is a common and effective treatment for several ocular diseases. However it is often complicated with the elevation of intraocular pressure (IOP). Anecortave acetate (AA) is an analog of cortisol acetate and lacks the typical anti-inflammatory and immunosuppressive properties of glucocorticoids. The effect of its anterior juxtascleral depot (AJD) injection has been evaluated in cases of glaucoma caused by intravitreal triamcinolone acetonide, presenting impressive results. The purpose of this study is to evaluate the efficacy and safety of the AA injection as a possible antiglaucoma treatment alternative. Methods: A prospective clinical study will be carried out including 30 glaucoma patients (30 eyes). After inclusion each patient will receive a single AJD injection of 30 mg of AA in the selected eye. Main outcome measure include: intraocular pressure at 1st day, 7th day, 1st, 2nd and 3rd months.